Publication | Closed Access

Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice

ImmunologyCerebrovascular DiseaseNeuroinflammationInflammationThrombosisStrokeNeurologyMiddle-aged MiceNeuroimmunologyAtherosclerosisIschemic SyndromeAutoimmunityVascular BiologyCerebral Blood FlowReperfusion InjuryInfarct SizeIschemic StrokeStroke-related ConditionExperimental Ischemic StrokeMedicine